SMD Rise Reclassifies Medical Diagnostic Subsidiary to Joint Venture

SMD Rise Public Company Limited (mai: SMD100) has informed the Stock Exchange of Thailand that SMD Rimag (Thailand) Co., Ltd. has been reclassified from a subsidiary to a joint venture of the company. This change does not affect the shareholding structure, registered capital, business objectives, composition of the Board of Directors, or sources of funding as previously disclosed.

On October 2, SMD100 established SMD Rimag as a subsidiary with a total registered capital of THB 10 million, of which the company holds 51 percent of the shares and Rimag Group (Thailand) Co., Ltd. (Rimag Thailand) holds the remaining 49 percent of the shares.

SMD Rimag is a company that provides medical diagnostic imaging services in Thailand using advanced imaging technologies, including X-ray, ultrasound, CT scan, PET/CT, MRI, radiation therapy, and digital health solutions, serving hospitals and customers of related projects.